Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Andrew J K. Östör »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Andrew J K. Ostör < Andrew J K. Östör < Andrew J. Long  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000425 (2019) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000673 (2018) Christopher J. Edwards [Royaume-Uni] ; Andrew J K. Östör [Australie] ; Barbara Naisbett-Groet ; Patrick Kiely [Royaume-Uni]Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.
001042 (2015) Andra F. Negoescu [Royaume-Uni] ; Andrew J K. Östör [Royaume-Uni]Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab.
001121 (2015) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör ; José Alvaro-Gracia ; Karel Pavelka ; José Andrés Román Ivorra ; Winfried Graninger ; William Bensen ; Michael T. Nurmohamed ; Andreas Krause ; Corrado Bernasconi ; Maher Aassi ; Jean SibiliaErratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
001160 (2015) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör ; José Alvaro-Gracia ; Karel Pavelka ; José Andrés Román Ivorra ; Winfried Graninger ; William Bensen ; Michael T. Nurmohamed ; Andreas Krause ; Corrado Bernasconi ; Maher Aassi ; Jean SibiliaComparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
001187 (2015) Muhammad K. Nisar [Royaume-Uni] ; Aneesa Rafiq [Royaume-Uni] ; Andrew J K. Östör [Royaume-Uni]Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
001754 (2012) Sooha Kim [Royaume-Uni] ; Andrew J K. Östör ; Muhammad K. NisarInterleukin-6 and cytochrome-P450, reason for concern?
001860 (2011) Laura Campbell [Royaume-Uni] ; Chen Chen ; Shweta S. Bhagat ; Richard A. Parker ; Andrew J K. ÖstörRisk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Andrew J K. Östör" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Andrew J K. Östör" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Andrew J K. Östör
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021